As of Mar 24
| -0.05 / -0.89%|
The 4 analysts offering 12-month price forecasts for Genocea Biosciences Inc have a median target of 17.00, with a high estimate of 40.00 and a low estimate of 15.00. The median estimate represents a +204.11% increase from the last price of 5.59.
The current consensus among 5 polled investment analysts is to Buy stock in Genocea Biosciences Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.